Research groups within DDB augment cell-based pharmacology with pre-clinical studies utilising native tissues and in vivo models of disease.
We have active collaborations with the pharmaceutical industry to identify novel drug targets and to test potential lead compounds, while the relationships between drug action, pharmacokinetics and pharmacodynamics are evaluated in collaboration with the Centre for Drug Candidate Optimisation at MIPS.
|Analytical & Structural Neuropharmacology||Cancer & Neural-Immune Regulation|
|Dr Celine Valant||Dr David Thal||Prof Arthur Christopoulos||A/Prof Erica Sloan|
|Cardiac GPCR Pharmacology||Cellular & Molecular Metabolism|
|Dr Lauren May||A/Prof Paul White||Prof Mark Febbraio|
|Heart Failure Pharmacology||Integrated Neurogenic Mechanisms|
|Prof Rebecca Ritchie||Dr Simona Carbone||Dr Daniel Poole||Dr Nicholas Veldhuis|
|Male Reproductive Pharmacology||Metabolic GPCR Biology|
|Dr Sab Ventura||Dr Betty Exintaris||Prof Patrick Sexton||A/Prof Denise Wootten|
|Molecular & Translational Drug Discovery|
|Dr Chris Langmead|